Valneva SE (VALN)
Nasdaq: VALN · Biological Products, (No Diagnostic Substances) · Saint-Herblain, FR · filing with the SEC since 2021
Who owns Valneva SE
As filed with the SECHolders of 5% or more
1
Caisse des depots et consignations holds 9.3% of Ordinary Shares, nominal value EUR0.15 per share, as its SCHEDULE 13D/A filed May 12, 2026 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Caisse des depots et consignations
SCHEDULE 13D/A · filed May 12, 2026 · Ordinary Shares, nominal value EUR0.15 per share · 10.5% in Mar 10, 2026
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G · filed May 12, 2026 · Ordinary Shares, nominal value EURO0.15 per share, represented by American Depository Shares · reported falling below 5%
What VALN reports owning in othersstakes of 5% or more, and other ties
9 subsidiaries in 6 countries, from the list filed with the 20-F filed Mar 22, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.